PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms

Journal of Cellular and Molecular Medicine

Weihua Li¹  Huimin Bai¹  Zhenyu Zhang¹  Xuan Jiang¹  Xiaoying Li¹ 

[1] Department of Obstetrics and Gynecology, Beijing Chao‐yang Hospital, Capital Medical University, Beijing, China;

关键词: BRCA1/2;    homologous recombination deficiency;    ovarian cancer;    PARP inhibitor;    resistance mechanism;   

DOI  :  10.1111/jcmm.14133

来源: Wiley

【 授权许可】

CC BY